Canagliflozin and risk of amputation in patients with type 2 diabetes

Sodium glucose co-transporter type 2 inhibitors amundsen field slacks herre (SGLT2) are a new effective group of oral hypoglygemic drugs for the treatment of diabetes type 2.At the moment there is no unanimous opinion on their safety.The article presents the data on clinical studies CANVAS and CANVAS-R and reports of the international database VigiBase (2015 - 2017) on the risk shibori dot fabric of amputation in patients with type 2 diabetes undergoing treatment with canagliflozin.